Skip to main content

Month: March 2023

VALHI REPORTS FOURTH QUARTER 2022 RESULTS

Dallas, Texas, March 09, 2023 (GLOBE NEWSWIRE) — Valhi, Inc. (NYSE: VHI) reported a net loss attributable to Valhi stockholders of $9.4 million, or $.33 per share, in the fourth quarter of 2022 compared to net income of $52.0 million, or $1.83 per share, in the fourth quarter of 2021. For the full year of 2022, Valhi reported net income attributable to Valhi stockholders of $90.2 million, or $3.16 per share compared to net income of $127.2 million, or $4.46 per share for the full year of 2021. Net income attributable to Valhi stockholders decreased in the fourth quarter of 2022 and the full year of 2022 compared to the same periods in 2021 primarily due to the effects of lower operating results from our Chemicals Segment and our Real Estate Management and Development Segment further discussed below. The Chemicals Segment’s net...

Continue reading

HCI Group Reports Fourth Quarter and Full Year 2022 Results

Florida Passes Historic Tort ReformsFourth Quarter Gross Loss Ratio Declined to 39.4% TAMPA, Fla., March 09, 2023 (GLOBE NEWSWIRE) — HCI Group, Inc. (NYSE:HCI), a holding company with operations in homeowners insurance, information technology services, real estate, and reinsurance, reported net income of $2.7 million, or $0.18 diluted earnings per share in the fourth quarter of 2022, compared with net income of $1.4 million, or $0.01 diluted earnings per share, in the fourth quarter of 2021. Adjusted net income (a non-GAAP measure which excludes net unrealized gains or losses on equity securities) for the fourth quarter of 2022 was $1.6 million, or $0.06 diluted earnings per share, compared with adjusted net loss of $0.1 million, or $0.14 loss per share, in the fourth quarter of 2021. This press release includes an explanation...

Continue reading

Trean Insurance Group Reports Fourth Quarter and Full Year 2022 Results

WAYZATA, Minn., March 09, 2023 (GLOBE NEWSWIRE) — Trean Insurance Group, Inc. (Nasdaq: TIG) (“Trean” or the “Company”), a leading provider of products and services to the specialty insurance market, today reported results for the fourth quarter and full year ended December 31, 2022. Fourth Quarter and Full Year 2022 HighlightsAnnounced definitive merger agreement with affiliates of Altaris, LLC (collectively with its affiliates, “Altaris”), which currently owns approximately 47% of Trean’s outstanding common stock. The transaction is expected to close during the first half of 2023, subject to certain closing conditions, including obtaining approval of a majority of the outstanding shares of Trean common stock held by stockholders that are not affiliated with Altaris and receiving certain regulatory approvals. Gross written premiums...

Continue reading

Aterian Reports Fourth Quarter & Full Year 2022 Results

  Achieved Substantial Progress Selling Through High Cost Inventory to Drive Margin Expansion Starting In the First Quarter of 2023 Reaffirms Second Half 2023 Adjusted EBITDA Profitability Target NEW YORK, March 09, 2023 (GLOBE NEWSWIRE) — Aterian, Inc. (Nasdaq: ATER) (“Aterian” or the “Company”) today announced results for the fourth quarter and full year ended December 31, 2022.  Fourth Quarter HighlightsFourth quarter 2022 net revenue declined 13.3% to $54.9 million, compared to $63.3 million in the fourth quarter of 2021. Fourth quarter 2022 gross margin declined to 37.1%, compared to 45.6% in the fourth quarter of 2021, primarily reflecting the impact of our strategy of liquidating high cost inventory. Fourth quarter 2022 contribution margin declined to (11.5)% from 7.9% in the fourth quarter of 2021, primarily reflecting...

Continue reading

springbig Reports Fourth Quarter and Full Year 2022 Financial Results

BOCA RATON, Fla., March 09, 2023 (GLOBE NEWSWIRE) — SpringBig Holdings, Inc. (“springbig” or the “Company”) (NASDAQ: SBIG), a leading provider of SaaS-based marketing solutions, consumer mobile app experiences, and omnichannel loyalty programs to the cannabis industry, today announced its financial results for the fourth quarter and full year ended December 31, 2022. Fourth Quarter 2022 Financial Highlights:Revenue* increased to $6.8 million, up 2% year-on-year Subscription revenue was up 33% year-on-year Net dollar retention rate was 105% for the twelve months ended December 31, 2022 Gross profit was $5.3 million, representing a gross profit margin of 78% Net loss was $(4.5) million compared to a loss of $(2.5) million in the prior year Adjusted EBITDA** loss was $(3.2) million compared to a loss of $(2.1) million in the prior...

Continue reading

CytoSorbents Reports Fourth Quarter and Full Year 2022 Results

Pivotal U.S. and Canada STAR-T Trial enrollment passes halfway mark. Positive sales momentum from Q4 2022 continues in Q1 2023 to date, with expectation of sales growth in 2023 PRINCETON, N.J., March 09, 2023 (GLOBE NEWSWIRE) — CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification via its proprietary polymer adsorption technology, today reported financial and operating results for the quarter and year ended December 31, 2022 and provides its 2023 outlook. Full Year 2022 Financial Results2022 Total Revenue, which includes Product Sales and Grant Income, was $34.7 million versus $43.2 million in 2021, a decrease of 20% 2022 Product sales were $29.4 million versus $40.1 million in 2021, which included $0.3 million...

Continue reading

Whitestone REIT Declares Second Quarter 2023 Dividend

HOUSTON, March 09, 2023 (GLOBE NEWSWIRE) — Whitestone REIT (NYSE: WSR) (“Whitestone” or the “Company”) today announced that its Board of Trustees has declared a monthly cash dividend of $0.04 per share on the Company’s common shares and operating partnership units for the second quarter of 2023. The dividend represents a quarterly amount of $0.12 per share, and an annualized amount of $0.48 per share. “At Whitestone, we are successfully executing on our growth strategy and improving the Company’s financial and operational performance to deliver even greater returns for shareholders,” said Dave Holeman, Whitestone’s CEO. “The current dividend provides shareholders with an approximate 5% yield and allows the company to focus on our target of bringing debt/EBITDAre to approximately 7x by year-end 2023.” The second quarter dividend...

Continue reading

Americold Realty Trust, Inc. Declares First Quarter 2023 Dividend

ATLANTA, GA., March 09, 2023 (GLOBE NEWSWIRE) — Americold Realty Trust, Inc. (NYSE: COLD) (the “Company” or “Americold”), the world’s largest publicly traded REIT focused on the ownership, operation, acquisition, and development of temperature-controlled warehouses, today announced that its Board of Directors has declared a dividend of $0.22 per share for the first quarter of 2023, payable to holders of the Company’s common stock. The dividend will be payable in cash on April 14, 2023 to stockholders of record at the close of business on March 31, 2023. About Americold Realty Trust, Inc. Americold is the world’s largest publicly traded REIT focused on the ownership, operation, acquisition and development of temperature-controlled warehouses. Based in Atlanta, Georgia, Americold owns and/or operates 242 temperature-controlled warehouses,...

Continue reading

Alpha Tau Medical Announces Full Year 2022 Financial Results and Provides Corporate Update

– Opened U.S. pivotal trial in recurrent cutaneous squamous cell carcinoma, which began enrolling patients in March – – Received Health Canada approval to initiate a liver cancer feasibility trial – – Pursued supply chain expansion in Israel, the U.S. and Japan, including increases in radioactive license capacities – – Cash & equivalents balance of $105.4 million, with runway for at least two years – JERUSALEM, March 09, 2023 (GLOBE NEWSWIRE) — Alpha Tau Medical Ltd. (“Alpha Tau”, or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, reported full year 2022 financial results and provided a corporate update. “We are proud of the team’s significant accomplishments in 2022, an important year...

Continue reading

AgileThought, Inc. Reports Fourth Quarter and Full Year 2022 Financial Results

IRVING, Texas, March 09, 2023 (GLOBE NEWSWIRE) — AgileThought, Inc. (“AgileThought” or the “Company”) (NASDAQ: AGIL), a global provider of digital transformation services, custom software development, and next generation technologies, today reported results for the fourth quarter and full year ended December 31, 2022. Fourth Quarter 2022 Highlights and Results:Revenue was $43.1 million, up 2.3% year over year from $42.1 million in Q4 2021 and down 0.8% sequentially from $43.4 million in Q3 2022, as the company continues to exit non-core revenues Gross margin was 31.6%, up 190 bps year-over-year from 29.7% in Q4 2021, but down 270 bps sequentially from 34.3% in Q3 2022 3 new clients added during the quarter.2022 Full Year Highlights and Results:Revenue was $176.8 million for 2022, up 11.5% year-over-year Gross margin was 32.6%,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.